Neocortical hyperexcitability after GABA withdrawal in vitro.
The sharp interruption of the intracortical instillation of exogenous gamma-aminobutyric acid (GABA), generates an epileptic focus in mammals. Seizures elicited by GABA withdrawal last several days or weeks. The present work reports that GABA withdrawal-induced hyperexcitability can be produced in vitro: a sudden withdrawal of GABA (5 mM; 120 min) or benzodiazepine (60 microM flunitrazepam) from the superfusion, induced a gradual increase in the amplitude of the evoked population spike (PS) recorded on neocortical slices. PS enhancement reached 150% above the control value 2.5 h after GABA withdrawal. GABA withdrawal-induced hyperexcitability was facilitated by progesterone. PS enhancement induced by GABA withdrawal was associated with an impairment of GABA transmission occurring before epileptiform discharges were fully established. Paired pulse inhibition and evoked [3H]-GABA release appear decreased; suggesting that cortical hyperexcitability as a result of GABA withdrawal involves pre-synaptic changes. Specific muscimol binding decreased during GABA superfusion but recovered after GABA withdrawal. However, the sensitivity of the post-synaptic response to 3alpha-OH-5alpha-pregnan-20-one or allopregnanolone (alloP) was enhanced after GABA withdrawal, suggesting a functional change in the GABA(A) receptors. The changes described may be the cellular correlates of the withdrawal syndromes appearing after interruption of the administration of GABA(A) receptor agonists.
Calixto
E
E
Instituto de Fisiología Celular, UNAM, Mexico City DF, Mexico.
López-Colomé
A M
AM
Casasola
C
C
Montiel
T
T
Bargas
J
J
Brailowsky
S
S
D000818:Animals; D005445:Flunitrazepam / Q000009:adverse effects; D018755:GABA Agonists / Q000378:metabolism; D018757:GABA Modulators / Q000009:adverse effects; D009118:Muscimol / Q000378:metabolism; D019579:Neocortex / Q000187:drug effects* / Q000378:metabolism; D011280:Pregnanolone / Q000009:adverse effects; D011374:Progesterone / Q000009:adverse effects; D051381:Rats; D017208:Rats, Wistar; D012640:Seizures / Q000139:chemically induced* / Q000378:metabolism; D013375:Substance Withdrawal Syndrome / Q000378:metabolism*; D009435:Synaptic Transmission / Q000187:drug effects* / Q000502:physiology; D005680:gamma-Aminobutyric Acid / Q000009:adverse effects* / Q000493:pharmacokinetics
D018755:GABA Agonists; D018757:GABA Modulators; D009118:Muscimol; D011374:Progesterone; D005680:gamma-Aminobutyric Acid; D005445:Flunitrazepam; D011280:Pregnanolone